These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35292069)

  • 1. HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data).
    Barré T; Mercié P; Lions C; Miailhes P; Zucman D; Aumaître H; Esterle L; Sogni P; Carrieri P; Salmon-Céron D; Marcellin F;
    AIDS Res Ther; 2022 Mar; 19(1):15. PubMed ID: 35292069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study).
    Barré T; Mercié P; Marcellin F; Esterle L; Duvivier C; Teicher E; Bureau M; Chas J; Salmon-Céron D; Sogni P; Carrieri MP; Wittkop L; Protopopescu C;
    AIDS Behav; 2021 Dec; 25(12):4141-4153. PubMed ID: 33903998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of patients' socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients.
    Yaya I; Roux P; Marcellin F; Wittkop L; Esterle L; Spire B; Dominguez S; Elegbe BA; Piroth L; Sogni P; Salmon-Ceron D; Carrieri MP;
    PLoS One; 2018; 13(7):e0199874. PubMed ID: 29975764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH).
    Marcellin F; Brégigeon-Ronot S; Ramier C; Protopopescu C; Gilbert C; Di Beo V; Duvivier C; Bureau-Stoltmann M; Rosenthal E; Wittkop L; Salmon-Céron D; Carrieri P; Sogni P; Barré T; ; ; ; ;
    JHEP Rep; 2023 Jan; 5(1):100614. PubMed ID: 36466990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort).
    Santos ME; Protopopescu C; Sogni P; Yaya I; Piroth L; Bailly F; Marcellin F; Esterle L; Wittkop L; Rosenthal E; Morlat P; Roux P; de Araujo WN; Salmon-Ceron D; Carrieri MP;
    AIDS Behav; 2020 Apr; 24(4):1069-1084. PubMed ID: 31286317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysis.
    Chalouni M; Pol S; Sogni P; Fontaine H; Lacombe K; Lacombe JM; Esterle L; Dorival C; Bourlière M; Bani-Sadr F; de Ledinghen V; Zucman D; Larrey D; Salmon D; Carrat F; Wittkop L; ; Martinez V
    HIV Med; 2021 Nov; 22(10):924-935. PubMed ID: 34402547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH).
    Mora M; Goodyear T; Marcellin F; Shoveller J; Di Beo V; Calzolaio C; Sogni P; Wittkop L; Zucman D; Poizot-Martin I; Lacombe K; Salmon-Céron D; Knight R; Carrieri P
    J Viral Hepat; 2020 Dec; 27(12):1462-1472. PubMed ID: 32810905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort.
    Knight R; Roux P; Vilotitch A; Marcellin F; Rosenthal E; Esterle L; Boué F; Rey D; Piroth L; Dominguez S; Sogni P; Salmon-Ceron D; Spire B; Carrieri MP;
    Addiction; 2017 Sep; 112(9):1669-1679. PubMed ID: 28430385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis Use as a Protective Factor Against Overweight in HIV-Hepatitis C Virus Co-Infected People (ANRS CO13 HEPAVIH Cohort).
    Barré T; Sogni P; Zaegel-Faucher O; Wittkop L; Marcellin F; Carrieri P; Gervais A; Levier A; Rosenthal E; Salmon-Céron D; Protopopescu C;
    AIDS Educ Prev; 2022 Aug; 34(4):272-290. PubMed ID: 35994579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).
    Marcellin F; Lions C; Rosenthal E; Roux P; Sogni P; Wittkop L; Protopopescu C; Spire B; Salmon-Ceron D; Dabis F; Carrieri MP;
    Drug Alcohol Rev; 2017 Mar; 36(2):227-238. PubMed ID: 27073179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of direct-acting antiviral regimens in HIV/HCV-co-infected patients - French ANRS CO13 HEPAVIH cohort.
    Piroth L; Wittkop L; Lacombe K; Rosenthal E; Gilbert C; Miailhes P; Carrieri P; Chas J; Poizot-Martin I; Gervais A; Dominguez S; Neau D; Zucman D; Billaud E; Morlat P; Aumaitre H; Lascoux-Combe C; Simon A; Bouchaud O; Teicher E; Bani-Sadr F; Alric L; Vittecoq D; Boué F; Duvivier C; Valantin MA; Esterle L; Dabis F; Sogni P; Salmon D;
    J Hepatol; 2017 Jul; 67(1):23-31. PubMed ID: 28235612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus-co-infected patients (ANRS CO13-HEPAVIH).
    Nordmann S; Vilotitch A; Roux P; Esterle L; Spire B; Marcellin F; Salmon-Ceron D; Dabis F; Chas J; Rey D; Wittkop L; Sogni P; Carrieri P;
    J Viral Hepat; 2018 Feb; 25(2):171-179. PubMed ID: 28984055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
    Pradat P; Pugliese P; Poizot-Martin I; Valantin MA; Cuzin L; Reynes J; Billaud E; Huleux T; Bani-Sadr F; Rey D; Frésard A; Jacomet C; Duvivier C; Cheret A; Hustache-Mathieu L; Hoen B; Cabié A; Cotte L;
    J Infect; 2017 Sep; 75(3):234-241. PubMed ID: 28579302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort].
    Michel L; Lions C; Winnock M; Lang JP; Loko MA; Rosenthal E; Marchou B; Valantin MA; Morlat P; Roux P; Sogni P; Spire B; Poizot-Martin I; Lacombe K; Lascoux-Combe C; Duvivier C; Neau D; Dabis F; Salmon-Ceron D; Carrieri MP;
    HIV Med; 2016 Nov; 17(10):758-765. PubMed ID: 27187027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort.
    Marcellin F; Miailhes P; Santos M; Mercié P; Di Beo V; Salmon-Céron D; Barré T; Wittkop L; Protopopescu C; Zucman D; Sogni P; Carrieri P;
    Clin Infect Dis; 2020 Dec; 71(9):2536-2538. PubMed ID: 32055846
    [No Abstract]   [Full Text] [Related]  

  • 16. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.
    Loko MA; Salmon D; Carrieri P; Winnock M; Mora M; Merchadou L; Gillet S; Pambrun E; Delaune J; Valantin MA; Poizot-Martin I; Neau D; Bonnard P; Rosenthal E; Barange K; Morlat P; Lacombe K; Gervais A; Rouges F; See AB; Lascoux-Combe C; Vittecoq D; Goujard C; Duvivier C; Spire B; Izopet J; Sogni P; Serfaty L; Benhamou Y; Bani-Sadr F; Dabis F;
    BMC Infect Dis; 2010 Oct; 10():303. PubMed ID: 20969743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep disturbances in HIV-HCV coinfected patients: indications for clinical management in the HCV cure era (ANRS CO13 HEPAVIH cohort).
    Costa M; Rojas TR; Lacoste D; Villes V; Aumaitre H; Protopopescu C; Yaya I; Wittkop L; Krause J; Salmon-Céron D; Marcellin F; Sogni P; Carrieri MP;
    Eur J Gastroenterol Hepatol; 2019 Dec; 31(12):1508-1517. PubMed ID: 31094856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).
    Marcellin F; Di Beo V; Aumaitre H; Mora M; Wittkop L; Duvivier C; Protopopescu C; Lacombe K; Esterle L; Berenger C; Gilbert C; Bouchaud O; Poizot-Martin I; Sogni P; Salmon-Ceron D; Carrieri P;
    J Hepatol; 2020 Mar; 72(3):588-591. PubMed ID: 31924411
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada.
    Marathe G; Moodie EEM; Brouillette MJ; Lanièce Delaunay C; Cox J; Martel-Laferrière V; Gill J; Cooper C; Pick N; Vachon ML; Walmsley S; Klein MB;
    Clin Infect Dis; 2023 Feb; 76(3):e702-e709. PubMed ID: 35789253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to: "Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)".
    Evon DM; Sarkar S; Amador J; Lok AS; Sterling RK; Stewart PW; Reeve BB; Serper M; Reau N; Reddy KR; Di Bisceglie AM; Nelson DR; Golin CE; Lim JK; Fried MW
    J Hepatol; 2020 Mar; 72(3):592-593. PubMed ID: 31889556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.